Paclitaxel or sirolimus. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Cell Line, Tumor Microtubules Chyle Tumor Cells, Cultured Kidney

Organisms3

Taxus Mice, Nude Citrus paradisi

Diseases24

Ovarian Neoplasms Lung Neoplasms Breast Neoplasms Lymphangioleiomyomatosis Carcinoma, Non-Small-Cell Lung Angiomyolipoma Neutropenia Coronary Restenosis Lymphangiomyoma Neoplasms Peripheral Nervous System Diseases Fallopian Tube Neoplasms Disease Progression Peritoneal Neoplasms Neoplasms, Glandular and Epithelial Leukopenia Hematologic Diseases Thrombocytopenia Thrombotic Microangiopathies Carcinoma Neoplasm Recurrence, Local Carcinoma, Squamous Cell Adenocarcinoma Polycystic Kidney, Autosomal Dominant

Chemicals and Drugs49

Paclitaxel Sirolimus Antineoplastic Agents, Phytogenic Immunosuppressive Agents Tacrolimus Carboplatin Cyclosporine Mycophenolic Acid Tubulin Modulators Calcineurin Cisplatin Antineoplastic Agents Taxoids Doxorubicin Bridged Compounds TOR Serine-Threonine Kinases P-Glycoprotein Tubulin Epothilones Antibiotics, Antineoplastic Pharmaceutical Vehicles Deoxycytidine Drug Carriers Antibodies, Monoclonal, Humanized Cardiovascular Agents Epirubicin Coated Materials, Biocompatible Topotecan Vinblastine Drug Implants Polyenes Creatinine Antibodies, Monoclonal Polymers Cyclophosphamide Ifosfamide Polyethylene Glycols Fluorouracil Granulocyte Colony-Stimulating Factor Albumins Platinum Compounds Oxaloacetic Acid Estramustine Micelles Polyglutamic Acid Cytochrome P-450 CYP3A Radiation-Sensitizing Agents Cyclosporins Azathioprine

Analytical, Diagnostic and Therapeutic Techniques and Equipment40

Antineoplastic Combined Chemotherapy Protocols Kidney Transplantation Drug Administration Schedule Treatment Outcome Infusions, Intravenous Drug Substitution Area Under Curve Disease-Free Survival Maximum Tolerated Dose Pharmaceutical Vehicles Drug Therapy, Combination Survival Analysis Drug Delivery Systems Drug Carriers Drug-Eluting Stents Survival Rate Injections, Intraocular Combined Modality Therapy Administration, Oral Stents Liver Transplantation Follow-Up Studies Xenograft Model Antitumor Assays Transplantation, Homologous Neoplasm Staging Drug Monitoring Drug Screening Assays, Antitumor Retrospective Studies Feasibility Studies Kaplan-Meier Estimate Immunosuppression Islets of Langerhans Transplantation Glomerular Filtration Rate Transplantation Fluorescence Polarization Immunoassay Prospective Studies Pilot Projects Chemotherapy, Adjuvant Inhibitory Concentration 50 Absorbable Implants

Phenomena and Processes15

Graft Rejection Dose-Response Relationship, Drug Drug Resistance, Neoplasm Drug Synergism Time Factors Area Under Curve Maximum Tolerated Dose Graft Survival Drug Interactions Apoptosis Drug Resistance, Multiple Cell Proliferation Glomerular Filtration Rate Cell Survival Inhibitory Concentration 50

Disciplines and Occupations1

Chemistry, Pharmaceutical

Technology, Industry, Agriculture4

Coated Materials, Biocompatible Nanoparticles Polymers Polyethylene Glycols

Information Science1

Health Care12

Treatment Outcome Drug Substitution Area Under Curve Disease-Free Survival Survival Analysis Survival Rate Follow-Up Studies Retrospective Studies Feasibility Studies Kaplan-Meier Estimate Prospective Studies Pilot Projects

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Paclitaxel Sirolimus Antineoplastic Agents, Phytogenic Immunosuppressive Agents Tacrolimus Antineoplastic Combined Chemotherapy Protocols Carboplatin Cyclosporine Kidney Transplantation Drug Administration Schedule Mycophenolic Acid Tubulin Modulators Calcineurin Treatment Outcome Ovarian Neoplasms Graft Rejection Dose-Response Relationship, Drug Drug Resistance, Neoplasm Cisplatin Infusions, Intravenous Lung Neoplasms Antineoplastic Agents Taxoids Drug Substitution Breast Neoplasms Doxorubicin Bridged Compounds Lymphangioleiomyomatosis Carcinoma, Non-Small-Cell Lung Angiomyolipoma Drug Synergism TOR Serine-Threonine Kinases Cell Line, Tumor Time Factors Neutropenia Area Under Curve Taxus Disease-Free Survival Maximum Tolerated Dose Coronary Restenosis P-Glycoprotein Tubulin Epothilones Antibiotics, Antineoplastic Pharmaceutical Vehicles Drug Therapy, Combination Deoxycytidine Graft Survival Survival Analysis Drug Interactions Lymphangiomyoma Drug Delivery Systems Drug Carriers Neoplasms Antibodies, Monoclonal, Humanized Drug-Eluting Stents Survival Rate Injections, Intraocular Cardiovascular Agents Apoptosis Peripheral Nervous System Diseases Epirubicin Mice, Nude Fallopian Tube Neoplasms Microtubules Coated Materials, Biocompatible Topotecan Vinblastine Combined Modality Therapy Drug Implants Administration, Oral Chyle Polyenes Tumor Cells, Cultured Nanoparticles Stents Liver Transplantation Follow-Up Studies Xenograft Model Antitumor Assays Drug Resistance, Multiple Transplantation, Homologous Neoplasm Staging Kidney Cell Proliferation Creatinine Drug Monitoring Drug Screening Assays, Antitumor Antibodies, Monoclonal Retrospective Studies Feasibility Studies Polymers Kaplan-Meier Estimate Disease Progression Chemistry, Pharmaceutical Cyclophosphamide Peritoneal Neoplasms Ifosfamide Immunosuppression Neoplasms, Glandular and Epithelial Leukopenia

No FAQ available that match "paclitaxel or sirolimus"